Insulin is a peptide hormone produced by the pancreas and is central to regulating carbohydrate and fat metabolism in the body. Insulin therapy is used for the treatment of people with type 1 diabetes in order to avoid complications arising from hyperglycemia. Insulin is administered mainly through subcutaneous insulin injections such as vials and syringes, insulin pens, and insulin pumps. In addition to this, various other physiological minimally invasive or noninvasive ways for delivering insulin are oral, buccal, nasal, peritoneal and transdermal.

Global insulin market has witnessed strong growth owing to various underlying favorable dynamics. Growth of the market is propelled by increasing incidences of diabetes, rise in geriatric population, growing the obese population, propagation of Diabetes management awareness and government impetus. However, the market faces several challenges such as high cost of insulin pumps, insurance coverage issues, regulatory pressure and technological issues.

The report “Global Insulin Delivery Device Market – (By Type-Vials & Syringes, Insulin Pens & Insulin Pumps; By Region- North America, Europe & Asia Pacific) Market Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global insulin delivery devices market with coverage on major market segments such as Vials & Syringes, Insulin Pens & Insulin Pumps. Future forecasts of insulin delivery devices market overall and across various sub-segments till 2025 is provided in the report. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.

Major industry players operating in the global insulin delivery devices market include Novo Nordisk, Sanofi Aventis, Eli Lilly and Company, Merck & Co., among others. These players are profiled herein based on attributes such as business overview, product segments, and financial analysis. It also compiles the performance comparison of the aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in the global insulin delivery devices market.

Key Factors Impacting Market Growth:

  • Increase the incidences of diabetes
  • The rise in geriatric population
  • Growing obese population

What Does This Report Provide?

This report provides a detailed understanding of the global insulin delivery devices market from qualitative and quantitative perspectives during the forecast period. The report also provides dynamic indicators with potential impact on the market during the forecast period and an in-depth analysis of the leading companies operating in the market.

Market Segmentation:

By Type:

  • Insulin Pen
  • Insulin Vial
  • Syringes and Insulin Pumps

By Region:

  • North America
    • By Type
  • Europe
    • By Type
  • Asia Pacific
    • By Type
  • Rest of the World
    • By Type

Companies Covered: Novo Nordisk, Sanofi Aventis, Eli Lilly and Company, Merck & Co.

 Reasons To Buy This Report:

  • Market size estimation of the global insulin delivery devices market on a regional and global basis
  • The unique research design for market size estimation and forecast
  • Profiling of major companies operating in the market with key developments
  • Broad scope to cover all the possible segments helping every stakeholder in the market


We provide customization of the study to meet specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country

For more information, contact: [email protected]

License Offerings

Single User License - USD 3999

Multi User License - USD 5499

Corporate License - USD 6999

Why QMI?

Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

Close Menu